Business Description
NGeneBio Co Ltd
ISIN : KR7354200008
Share Class Description:
XKRX:354200: Ordinary SharesCompare
Compare
Traded in other countries / regions
354200.Korea IPO Date
2020-12-10Description
NGeneBio Co Ltd is engaged in the business of developing companion diagnosis, disease diagnosis, and liquid biopsy products and bioinformatics software.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.13 | |||||
Debt-to-EBITDA | -1.61 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.38 | |||||
Beneish M-Score | -3.61 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.6 | |||||
3-Year EBITDA Growth Rate | 1.4 | |||||
3-Year EPS without NRI Growth Rate | -6.1 | |||||
3-Year FCF Growth Rate | -5.3 | |||||
3-Year Book Growth Rate | -28 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.81 | |||||
9-Day RSI | 44.98 | |||||
14-Day RSI | 46.63 | |||||
6-1 Month Momentum % | -40.65 | |||||
12-1 Month Momentum % | -57.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.52 | |||||
Quick Ratio | 0.52 | |||||
Days Inventory | 267.95 | |||||
Days Sales Outstanding | 59.77 | |||||
Days Payable | 19.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | -1.05 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40 | |||||
Operating Margin % | -160.38 | |||||
Net Margin % | -266.29 | |||||
FCF Margin % | -182.61 | |||||
ROE % | -86.38 | |||||
ROA % | -31.39 | |||||
ROIC % | -19.43 | |||||
ROC (Joel Greenblatt) % | -97.44 | |||||
ROCE % | -48.56 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.28 | |||||
PB Ratio | 3.28 | |||||
Price-to-Tangible-Book | 3.31 | |||||
EV-to-EBIT | -3.72 | |||||
EV-to-EBITDA | -4.21 | |||||
EV-to-Revenue | 6.58 | |||||
EV-to-FCF | -3.57 | |||||
Earnings Yield (Greenblatt) % | -26.9 | |||||
FCF Yield % | -25.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NGeneBio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 4,988.629 | ||
EPS (TTM) (â‚©) | -1035.954 | ||
Beta | 1.28 | ||
Volatility % | 40.16 | ||
14-Day RSI | 46.63 | ||
14-Day ATR (â‚©) | 288.590201 | ||
20-Day SMA (â‚©) | 3004 | ||
12-1 Month Momentum % | -57.18 | ||
52-Week Range (â‚©) | 2285 - 9800 | ||
Shares Outstanding (Mil) | 12.89 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NGeneBio Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NGeneBio Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
NGeneBio Co Ltd Frequently Asked Questions
What is NGeneBio Co Ltd(XKRX:354200)'s stock price today?
The current price of XKRX:354200 is â‚©2850.00. The 52 week high of XKRX:354200 is â‚©9800.00 and 52 week low is â‚©2285.00.
When is next earnings date of NGeneBio Co Ltd(XKRX:354200)?
The next earnings date of NGeneBio Co Ltd(XKRX:354200) is .
Does NGeneBio Co Ltd(XKRX:354200) pay dividends? If so, how much?
NGeneBio Co Ltd(XKRX:354200) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |